Ex Parte Robinson et alDownload PDFPatent Trial and Appeal BoardJul 20, 201612272257 (P.T.A.B. Jul. 20, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/272,257 11/17/2008 23909 7590 07/22/2016 COLGATE-PALMOLIVE COMPANY 909 RIVER ROAD PISCATAWAY, NJ 08855 FIRST NAMED INVENTOR Richard Scott Robinson UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 8153-03-0C 5954 EXAMINER MAEWALL, SNIGDHA ART UNIT PAPER NUMBER 1612 NOTIFICATION DATE DELIVERY MODE 07/22/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): Patent_Mail@colpal.com uspto@thebellesgroup.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RICHARD SCOTT ROBINSON, RICHARD J. SULLIVAN, MICHAEL PRENCIPE, RAJNISH KOHLI, ISABELLE VAN RYCKE, RICHARD LOVELL, SERGIO LEITE, ERIC A. SIMON, RALPH PETER SANTARPIA III, DIANE CUMMINS, SARITA V. MELLO, SUMAN CHOPRA, KAREN J. DEPIERRO, LYNETTE ZAIDEL, CONSTANTINA CHRISTOPOULOU, RA VI SUBRAMANY AM, DONGHUI WU, ANDRE M. MORGAN, QIN WANG, GARY EDWARD TAMBS, and VIRGINIA MONSUL BARNES Appeal2013-000901 Application 12/272,257 Technology Center 1600 Before DONALD E. ADAMS, RICHARD M. LEBOVITZ, and MELANIE L MCCOLLUM, Administrative Patent Judges. LEBOVITZ, Administrative Patent Judge. DECISION ON APPEAL This appeal involves claims directed to a periodic oral care maintenance composition and a primary oral care composition. Appellants appeal from the Examiner's final rejection of claims 1-10 as obvious under 35 U.S.C. § 103. We have jurisdiction under 35 U.S.C. § 134. The obviousness rejections are affirmed. Appeal2013-000901 Application 12/272,257 STATEMENT OF CASE Claims 1-10 stand finally rejected by the Examiner as follows: 1. Claims 1-10 under 35 U.S.C. § 103(a) (pre-AIA) as obvious in view ofDurga '933 (U.S. Pat. 6,290,933 Bl, issued Sep. 18, 2001), Yamagishi (EP 0 569 666 A2, published Nov. 18, 1993), Pocrovsky (English translation of middle column of page 2 84 of "Kratka ya meditsiskaya encyklopediya," Acad. RAMN. 1994), and Phillips (U.S. Publ. App. 2006/0216247 Al, published Sep. 28, 2006). Answer 5. 2. Claims 4 and 8 under 35 U.S.C. § 103(a) (pre-AIA) as obvious in view ofDurga '933, Yamagishi, Pocrovsky, Phillips, and Acevedo ("The Inhibitory Effect of an Arginine Bicarbonate/Calcium Carbonate (CaviStat®) Containing Dentifrice on the Development of Dental Caries in Venezuelan School Children," 16 J. Clin. Dent. 1-8, 2005). Id. at 10. 3. Claims 1-10 under 35 U.S.C. § 103(a) (pre-AIA) as obvious in view ofDurga '115 (WO 01/85115 A2, published Nov. 15, 2001) 1, Yamagishi, Pocrovsky, and Phillips. Id. at 11. 4. Claims 4 and 8 under 35 U.S.C. § 103(a) (pre-AIA) as obvious in view ofDurga '115, Yamagishi, Pocrovsky, Phillips, and Acevedo. Id. at 15-16. 5. Claims 1-10 as unpatentable on the ground of non-statutory obviousness-type double patenting over claims 1-9 of copending Application No. 12/028,782 in view of Durga '933. Id. at 16. The copending application was abandoned. See Notice of Abandonment dated Nov. 13, 2015. This rejection is therefore moot. 1 Durga '115 claims the priority benefit of the same U.S. patent application 09/567,402 as does Durga '933. 2 Appeal2013-000901 Application 12/272,257 There are two independent claims on appeal, claims 1 and 5. Claim 1 is representative and reads as follows: 1. A periodic oral care maintenance composition comprising a basic amino acid, in free or salt form, for use in the therapeutic treatment of an oral surface, which treatment comprises a. contacting the oral surface with a primary oral care composition at least once daily, and b. contacting the oral surface with the periodic oral care maintenance composition at least once monthly and less than once daily; wherein the periodic oral care maintenance composition further comprises a first abrasive having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions, wherein the ratio of the first abrasive to the second abrasive is about 1: 1.6 to about 1.6: 1. CLAIM INTERPRETATION Claim 1 is directed to a "periodic oral care maintenance composition." The composition comprises "a basic amino acid, in free or salt form," and "a first abrasive" and "a second abrasive." The first and second abrasives each have a specifically recited hardness and are present in a ratio of about 1: 1.6 to about 1.6: 1. The claim recites that the composition is "for use in the therapeutic treatment of an oral surface." The claim further recites that the "treatment comprises" steps a. and b. of contacting the oral surface with a "primary oral care composition" and "the periodic oral care maintenance composition," respectively. We interpret the "therapeutic treatment" steps to be an "intended use" of the claimed "periodic oral care maintenance composition" because it describes what the composition is to be used for, namely, for treatment of an oral surface. We reach this interpretation because the claim 3 Appeal2013-000901 Application 12/272,257 preamble explicitly states that the claim is directed to a "composition," defining the claim as a product composed of the basic amino acid and the first and second abrasives. The "terms appearing in a [claim] preamble may be deemed limitations of a claim when they 'give meaning to the claim and properly define the invention."' In re Paulsen, 30 F.3d 1475, 1479 (Fed. Cir. 1994). In this case, the claim preamble explicitly defines the invention as a periodic oral care maintenance composition. For this reason, the subsequent step in the claim reciting how often the periodic oral care composition is used ("at least once month and less than once daily") is an "intended use" of the composition, i.e., what it can be used for, but does not necessary limit or add additional characteristics to the periodic oral care composition which is claimed. Appellants have not identified how the "treatment" steps a) and b) change the structure of the claimed "periodic oral care maintenance composition." 1. REJECTION OVER DURGA, Y AMAGISHI, POCROVSKY, AND PHILLIPS The Examiner found that Durga '933 describes an oral dentifrice composition comprising two abrasives, each with a hardness meeting the claimed limitations. Answer 6, 11. The Examiner also found the abrasives were present in a ratio within the scope of the claim. Id. at 11. The Examiner found that Durga '933 does not describe a basic amino acid in its composition, but found that Y amagishi describes an oral care composition, which can be in the form of a toothpaste, that contains the basic amino acid arginine. Id. at 7. The Examiner concluded it would have been obvious to 4 Appeal2013-000901 Application 12/272,257 one of ordinary skill in the art to have utilized arginine in Durga '933 's composition to protect the tooth surface. Id. Appellants contend that there would have been no motivation to have added arginine to Durga '933 's composition because Yamagishi "uses arginine ... to neutralize the alkyl monophosphate esters required in Yamagishi's composition." Br. 12. Appellants argue that "Durga ['933] does not mention alkyl monophosphate esters. Therefore, there is no purpose, motivation or reason to combine the arginine taught by Yamagishi with the composition taught by Durga ['933]." Id. Appellants' argument does not persuasively demonstrate error in the Examiner's rejection. The Examiner found that Y amagishi describes an oral care composition comprising a basic amino acid and an abrasive, the same components recited in claim 1. Answer 7. Y amagishi specifically teaches (at 11 :35--42): 8. A paste composition for use in the oral cavity comprising: (A) a monophosphate represented by the general formula (2) of Claim 5, (B) a basic amino acid, (C) an abrasive, (D) a thickening agent, (E) a moisturizing agent, and (F) water. The (A) monophosphate protects the tooth surface (Yamagishi, Abstract (57), 2:10-22) and (B) the basic amino acid adds stability (id. at 2: 39--40). The (A) monophosphate is an alkyl monophosphate esters or an "AP." While it is true that Y amagishi adds a basic amino acid, such as arginine, to neutralize the alkyl phosphoric ester (the "monophosphate" of 5 Appeal2013-000901 Application 12/272,257 claim 8 of Y amagishi") in its composition to make it more stable (id. at 2: 41--44), one of ordinary skill in the art would have had reason to have utilized monophosphate (an "AP") and basic amino acid in a composition comprising oral abrasives, such as those described in Durga, because Y amagishi explicitly describes such a combination in its claim 8 to protect the tooth surface (Yamagishi, Abstract (57); 2:10-22). The claims are open- ended and do not exclude the addition of both the basic amino acid and the AP of Y amagishi. Accordingly, Appellants' argument that "there is no purpose, motivation or reason to combine the arginine taught by Yamagishi" is not supported by a preponderance of the evidence. Br. 12. Appellants contend that "Durga ['933] does not disclose use of the particular dentifrice at least once monthly but less than once daily, or use in a regimen in conjunction with another dentifrice." Id. This argument does not distinguish claim 1 from Durga because, as discussed above, claim 1 is directed to "composition," not a method of using the composition. Evidence has not been provided that the "intended use" of the claimed composition distinguishes it from the composition suggested by Durga '933 and Yamagishi. The question is whether Durga '933 's abrasives could be utilized "at least once monthly and less than once daily" as recited in claim 1. We have not been directed to evidence that they could not be used in this manner. Claim 5 Claim 5 is directed to a "combined preparation comprising a periodic oral care maintenance composition and a primary oral care composition." The claim has the same "intended use" steps recited in claim 1. For the 6 Appeal2013-000901 Application 12/272,257 same reasons as for claim 1, we conclude that the "intended use" steps do not distinguish the claim from the cited publications. The Examiner cited the Pocrovsky and Phillips publications as providing a reason to have used a dental abrasive ("periodic oral care maintenance composition") with a mouthwash ("primary oral care composition"). Answer 8-10. Appellants argue the "use" limitations of the claim, but do not identify a persuasive error in the Examiner's findings or conclusion that the claimed "combined preparation" of claim 5 would have been obvious to one of ordinary skill in the art. Summary We affirm the obviousness rejection of claims 1 and 5. Claims 2, 3, 6, 7, 9, and 10 fall with claims 1 and 5 because separate reasons for their patentability were not provided. 37 C.F.R. § 41.37(c)(l)(iv). Claim 4 and 8 were included in the rejection, but they were rejected in the rejection based on Acevedo. We thus address them separately below. REJECTION OVER DURGA '933, YAMAGISHI, POCROVSKY, PHILLIPS, AND ACEVEDO Dependent claims 4 and 8 further recite that the basic amino acid is selected from a list that includes arginine bicarbonate. Claim 4 depends from claim 3, which depends from claim 1. Claim 8 depends from claim 7, which depends from claim 5. In both claims, a periodic oral care maintenance composition is claimed. The Examiner further cited Acevedo for its teaching of "arginine bicarbonate/calcium carbonate containing dentifrice more effective in 7 Appeal2013-000901 Application 12/272,257 inhibiting caries and inducing remineralization." Answer 10. The Examiner found it was obvious to have utilized arginine bicarbonate/calcium carbonate in Durga '933 for its expected benefit. Id. at 10-11. Appellants contend that "the toothpaste is the primary oral care composition, whereas the arginine is required in the periodic oral care maintenance composition. Acevedo does not teach a composition containing arginine or other basic amino acids or the regimen claimed." Br. 15. The claims do not require the primary oral care composition to be a toothpaste as asserted by Appellants. Moreover, the pertinent question is whether it would have been obvious to have utilized arginine bicarbonate/calcium carbonate in Durga '933 's cleaning abrasive dentifrice. As found by the Examiner, Acevedo teaches arginine bicarbonate/calcium carbonate in a toothpaste. Based on extensive in vitro and in vivo experiments performed in our laboratories, arginine bicarbonate was combined \vith calcium carbonate (CaviStat®, Ortek Therapeutics, Inc., Roslyn Heights, NY, USA) to enable simultaneous inhibition of both acid production and enamel demineralization .... This has been formulated as the active in the CaviStat-containing toothpaste tested in this study. The arginine of the arginine bicarbonate in Ca vi Stat provides an effective means of countering the pH fall associated with the acid production component of the caries process. The calcium of the calcium carbonate provides a means of suppressing solubilization of the tooth enamel and favoring remineralization. Acevedo 2, col 1 (footnotes omitted). 8 Appeal2013-000901 Application 12/272,257 Durga '933 's cleaning abrasive can be in the form of a toothpaste: The total quantity of abrasive present in the dentifrice compositions of the present invention is at a level of from about 5% to about 40% by weight, preferably from about 5% to about 30% by weight when the dentifrice composition is a toothpaste. Durga '933, col. 4, 11. 41--45 In sum, both Durga '933 and Acevedo teach toothpastes. Consequently, the Examiner's conclusion that it would have been obvious to have included Acevedo's arginine in Durga '933 's composition is reasonable and fact-based since both publications describe toothpastes and Acevedo provides a reason to have utilized arginine bicarbonate/calcium carbonate in a toothpaste. Accordingly, the rejection of claims 4 and 8 is affirmed. REJECTIONS 3 AND 4 Rejections 3 and 4 are based on Durga '115 rather than Durga '933. Durga '115 appears to have the same disclosure as Durga '933. Appellants rely on the same arguments as they did for the rejections based on Durga '933. Br. 11-16. We affirm the rejections for the same reasons. TIME PERIOD No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED 9 Copy with citationCopy as parenthetical citation